CPT code 24006 is a medical billing code for the excision or release of the elbow capsule due to arthritis.
CPT code 24065 is used to describe a medical procedure involving the biopsy of soft tissue in the arm or elbow. This code is specifically utilized when a healthcare provider needs to remove a small sample of soft tissue from these areas for diagnostic purposes, such as to check for the presence of disease or abnormal cells. The procedure typically involves making a small incision to access the tissue, which is then sent to a laboratory for analysis.
When billing for CPT code 24065 (Biopsy, soft tissue of the arm or elbow area), it is essential to consider the appropriate use of modifiers to ensure accurate reimbursement and compliance with payer requirements. Below is a list of modifiers that could be used with CPT code 24065, along with the reasons for their use:
1. Modifier -50 (Bilateral Procedure): Used if the biopsy is performed on both arms or elbows during the same session.
2. Modifier -51 (Multiple Procedures): Applied when multiple procedures, including the biopsy, are performed during the same surgical session.
3. Modifier -59 (Distinct Procedural Service): Used to indicate that the biopsy is a distinct service from other procedures performed on the same day.
4. Modifier -RT (Right Side): Indicates that the biopsy was performed on the right arm or elbow.
5. Modifier -LT (Left Side): Indicates that the biopsy was performed on the left arm or elbow.
6. Modifier -76 (Repeat Procedure by Same Physician): Used if the biopsy procedure is repeated on the same day by the same physician.
7. Modifier -77 (Repeat Procedure by Another Physician): Applied if the biopsy procedure is repeated on the same day by a different physician.
8. Modifier -78 (Unplanned Return to the Operating/Procedure Room): Used if the patient requires an unplanned return to the operating room for a related procedure during the postoperative period.
9. Modifier -79 (Unrelated Procedure or Service by the Same Physician During the Postoperative Period): Indicates that the biopsy is unrelated to the original procedure and is performed during the postoperative period of another surgery.
10. Modifier -XE (Separate Encounter): Used to indicate that the biopsy was performed during a separate encounter on the same day as another procedure.
11. Modifier -XS (Separate Structure): Indicates that the biopsy was performed on a separate organ/structure from other procedures performed on the same day.
12. Modifier -XP (Separate Practitioner): Used when the biopsy is performed by a different practitioner on the same day as another procedure.
13. Modifier -XU (Unusual Non-Overlapping Service): Indicates that the biopsy does not overlap with other services performed on the same day.
Proper use of these modifiers ensures that the billing accurately reflects the services provided and helps avoid claim denials or delays in reimbursement. Always verify payer-specific guidelines as they may have unique requirements for modifier usage.
The CPT code 24065 is reimbursed by Medicare, but it is essential to verify the specific details through the Medicare Physician Fee Schedule (MPFS). The MPFS provides a comprehensive list of services covered by Medicare, including the reimbursement rates for each CPT code. Additionally, it is advisable to consult with your local Medicare Administrative Contractor (MAC) for any region-specific guidelines or requirements that may affect reimbursement. The MACs are responsible for processing Medicare claims and can provide detailed information on coverage and payment policies for CPT code 24065.
Discover the power of MD Clarity's RevFind software to ensure you're getting paid what you deserve. With RevFind, you can read your contracts and detect underpayments down to the CPT code level, including specific codes like 24065. Identify discrepancies by individual payer and take control of your revenue cycle. Schedule a demo today to see how RevFind can optimize your payment accuracy.
Get paid in full by bringing clarity to your revenue cycle
Subscribe to the
Healthcare Clarified newsletter
Get the latest insights on RCM and healthcare policy in your inbox
